RTW Biotech Opportunities Ltd (0BM)

Profile

https://www.rtwfunds.com/rtw-biotech-opportunities-ltd

RTW Biotech Opportunities Ltd is a Guernsey-domiciled closed-end investment fund specializing in the life sciences sector. It focuses on identifying and investing in transformative assets with high growth potential across biopharmaceuticals and medical technologies, targeting therapies and innovations that address severe diseases with limited treatment options and strong commercial prospects. Managed by RTW Investments, LP, the fund employs a full lifecycle approach, supporting companies from early academic programs to mature public entities, including genetic medicines, biologics, small molecules, antibodies, and medical devices. This data-driven strategy leverages deep scientific expertise and a long-term horizon to build a diversified portfolio aimed at superior capital appreciation and positive absolute returns. Notable holdings include Corxel Pharmaceuticals, Avidity Biosciences, and Akero Therapeutics, reflecting its emphasis on innovative healthcare advancements. Listed on the London Stock Exchange since 2019, with Chairman William Simpson and key figures like Roderick Wong, the fund plays a significant role in fueling biotechnology innovation and patient impact globally.